Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

264
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
264
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

284
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
284
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

205
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
205
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

242
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
242
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

274
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
274
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

155
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
155

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimizing imaging techniques in hypertrophic cardiomyopathy: challenges and opportunities.

European heart journal. Imaging methods and practice·2026
Same author

COVID-19 outcomes and persistent symptoms in patients with hypertrophic cardiomyopathy: association with pre-existing cardiovascular magnetic resonance phenotype.

Heart (British Cardiac Society)·2026
Same author

Long-term outcomes of obstructive hypertrophic cardiomyopathy undergoing surgical myectomy: Impact of symptom severity at presentation.

Cardiovascular research·2026
Same author

Emerging treatments in hypertrophic cardiomyopathy: a focus on cardiac myosin inhibitors.

Expert opinion on pharmacotherapy·2026
Same author

Mavacamten in Adolescents with Obstructive Hypertrophic Cardiomyopathy.

The New England journal of medicine·2026
Same author

EJHF expert consensus statement on the diagnosis and management of hypertrophic cardiomyopathy.

European journal of heart failure·2026

Related Experiment Video

Updated: Dec 6, 2025

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
10:39

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding

Published on: August 30, 2024

1.2K

Radiation-Associated Valvular Disease.

Samantha Xu1, Eoin Donnellan1, Milind Y Desai2,3

  • 1Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA.

Current Cardiology Reports
|October 11, 2020
PubMed
Summary
This summary is machine-generated.

Managing radiation-associated valvular disease (RAVD) requires early, consistent screening and careful planning. Integrated specialist teams and multimodality imaging are key for timely intervention and improved patient outcomes in RAVD.

Keywords:
CancerCardio-oncologyRadiation therapyRadiation-associated cardiac diseaseRadiation-associated valvular disease

More Related Videos

A Rabbit Aortic Valve Stenosis Model Induced by Direct Balloon Injury
07:10

A Rabbit Aortic Valve Stenosis Model Induced by Direct Balloon Injury

Published on: March 31, 2023

1.4K
Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
04:30

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat

Published on: February 4, 2021

3.6K

Related Experiment Videos

Last Updated: Dec 6, 2025

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
10:39

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding

Published on: August 30, 2024

1.2K
A Rabbit Aortic Valve Stenosis Model Induced by Direct Balloon Injury
07:10

A Rabbit Aortic Valve Stenosis Model Induced by Direct Balloon Injury

Published on: March 31, 2023

1.4K
Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
04:30

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat

Published on: February 4, 2021

3.6K

Area of Science:

  • Cardiology
  • Oncology
  • Radiology

Background:

  • Radiation-associated valvular disease (RAVD) presents as late-onset heart valve issues after mediastinal radiation therapy.
  • Understanding and managing RAVD is crucial for long-term cancer survivor care.

Purpose of the Study:

  • To review current guidelines for managing radiation-associated valvular disease (RAVD).
  • To identify best practices for risk reduction and outcome optimization in patients with RAVD.

Main Methods:

  • Systematic review of existing clinical guidelines for RAVD management.
  • Analysis of strategies for early detection, risk stratification, and intervention planning.

Main Results:

  • Early and consistent screening is critical for detecting RAVD due to its long latency.
  • Multimodality imaging and integrated specialist teams are essential for comprehensive management.
  • Individualized care plans with serial screening and expert decision-making improve outcomes.

Conclusions:

  • Proactive and integrated management is vital for patients with radiation-associated valvular disease.
  • Longitudinal, imaging-based screening and timely intervention are recommended for optimal patient care.